by NDNR | Mar 6, 2020 | 2020, Anxiety/Depression/Mental Health, Insomnia/Sleep Medicine, March
The Vital Conversation James Sensenig, ND This is the third part of a 3-part article from The Vital Conversation that took place on June 22, 2016. It is part of a new series of articles in NDNR that is based on transcripts of conversations that occurred on Wednesdays...
by NDNR | Mar 6, 2020 | 2020, Anxiety/Depression/Mental Health, Education, Insomnia/Sleep Medicine, March
Education David J. Schleich, PhD We’ve been sparring with the biomedicine industry all along the professional formation continuum (education, research, licensing) for a very long time. We have also been joining some aspects of the mainstream’s strategies for a...
by NDNR | Mar 6, 2020 | 2020, Anxiety/Depression/Mental Health, Insomnia/Sleep Medicine, March
Regenerative Medicine Fred G. Arnold, DC, NMD Platelet-Rich Plasma (PRP) is the third topic in my series about regenerative medicine treatments for painful musculoskeletal conditions. This regenerative injection procedure was originally used in 1987 following...
by NDNR | Mar 6, 2020 | 2020, Anxiety/Depression/Mental Health, Insomnia/Sleep Medicine, March
Tolle Causam Lauren Tessier, ND Illness resulting from mold and mycotoxin exposure is gaining more traction and attention. As the paradigm shift occurs, mold and mycotoxin-induced illness (MMII) should be brought to the forefront of clinical education, both in school...
by NDNR | Mar 5, 2020 | 2020, Anxiety/Depression/Mental Health, Insomnia/Sleep Medicine, March
Naturopathic Perspective Saul Marcus, ND Mitragyna speciosa (common name, kratom) is an herb from Southeast Asia. Traditionally, it has been used by workers to help them have more stamina during long workdays. A tea would be brewed from leaves, and consumed throughout...
by NDNR | Mar 5, 2020 | 2020, Anxiety/Depression/Mental Health, Insomnia/Sleep Medicine, March
Tolle Totum Jaclyn Graham, BSc, ND The prevalence of depression in type 1 diabetic patients may be 3 times higher than that of non-diabetic patients in the general population, while 40% of patients with type 1 diabetes also have anxiety.1 The consequences of...
